Idorsia (XSWX:IDIA) Ending Cash Position: CHF94.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:IDIA Idorsia Ltd XSWX:IDIA
48 GF Score
Price CHF5.92
GF Value CHF2.88
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Idorsia Ending Cash Position?

Idorsia XSWX:IDIA -4.29% 48 Ending Cash Position is CHF94.7 Mil as of Mar. 2026. GuruFocus rates XSWX:IDIA with a GF Score™ of 48/100 and a GF Value™ of CHF2.88 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Idorsia's Ending Cash Position for the quarter that ended in Mar. 2026 was CHF94.7 Mil.

Idorsia's quarterly Ending Cash Position increased from Sep. 2025 (CHF63.8 Mil) to Dec. 2025 (CHF88.5 Mil) and increased from Dec. 2025 (CHF88.5 Mil) to Mar. 2026 (CHF94.7 Mil).

Idorsia's annual Ending Cash Position declined from Dec. 2023 (CHF145.1 Mil) to Dec. 2024 (CHF106.4 Mil) and declined from Dec. 2024 (CHF106.4 Mil) to Dec. 2025 (CHF88.5 Mil).

Idorsia Ending Cash Position Related Terms

Idorsia Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Idorsia's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Idorsia Ending Cash Position Chart

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.35 146.00 145.05 106.38 88.54

Idorsia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.68 72.07 63.81 88.54 94.70
XSWX:IDIA
48GF Score
Idorsia Ltd XSWX:IDIA
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Idorsia Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Idorsia's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=106.376+-17.832
=88.5

Idorsia's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=88.543+6.154
=94.7

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of CHF94.7 Mil mean?
Idorsia (XSWX:IDIA) has a Ending Cash Position of CHF94.7 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Idorsia and its competitors.
Is Idorsia's Ending Cash Position too high?
Idorsia's current Ending Cash Position is CHF94.7 Mil. Overall, Idorsia has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Idorsia's Ending Cash Position compare to VRTX and REGN?
Idorsia's Ending Cash Position of CHF94.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Idorsia and its competitors. Idorsia's current Ending Cash Position is CHF94.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Idorsia stock overvalued right now?
Based on GuruFocus' analysis, Idorsia (XSWX:IDIA) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF2.88, compared to a current price of CHF5.92 — trading 105.4% above its estimated fair value. The current Ending Cash Position is CHF94.7 Mil. Idorsia's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Idorsia (XSWX:IDIA), the current Ending Cash Position is CHF94.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Idorsia (XSWX:IDIA) Overvalued in 2026?

Based on GuruFocus' analysis, Idorsia stock appears to be overvalued. The current stock price of CHF5.92 is trading 105.4% above its estimated GF Value™ of CHF2.88. GuruFocus considers Idorsia to be Significantly Overvalued.

Key valuation signals for XSWX:IDIA:

  • Ending Cash Position: CHF94.7 Mil
  • GF Value™: CHF2.88 vs. price of CHF5.92 (105.4% above fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the XSWX:IDIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Idorsia Business Description

Address Hegenheimermattweg 91, Allschwil, CHE, 4123
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. The company is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide new therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. The company's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
48GF Score

Get the complete analysis for XSWX:IDIA

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF5.92
Price
CHF2.88
GF Value